Source: Annual Congress 2012 - COPD treatment and varia
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Pertseva, K. Gashynova, O. Bratus, N. Petrik (Dnipropetrovsk, Ukraine). Serum surfactant protein D (SPD) as a specific marker for COPD. Eur Respir J 2012; 40: Suppl. 56, 3470

Member's Comments

No comment yet.

Related content which might interest you: Serum surfactant protein D (SPD) and response to the combined therapy in patients (pts) with stable COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Surfactant protein D as a potential serum marker of pulmonary emphysema Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention Year: 2011 COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Asthmatics with high levels of serum surfactant protein D have more severe disease Source: Eur Respir J 2016; 47:1864-1867 Year: 2016 Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population Source: Eur Respir J 2001; 18: 482-490 Year: 2001 COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Surfactant protein-A (SP-A) expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007 “Plasma pro-surfactant protein B and lung function decline in smokers.” Source: Eur Respir J 2016; 48: 962 Year: 2016 Surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with community acquired pneumonia (CAP) during the treatment program Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017 Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014 Sputum Vitamin D binding protein (VDBP) GC1S/1S genotype predicts airway obstruction: a prospective study in smokers with COPD Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Plasma pro-surfactant protein B and lung function decline in smokers Source: Eur Respir J 2015; 45: 1037-1045 Year: 2015 Surfactant protein D (SPD) and C-reactive protein (CRP) in patient with low respiratory tract infections (LRTI) Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Late-breaking abstract: Association between serum surfactant protein D (SP-D) and lung function measurements in self-reported healthy twins Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011